Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Antiseptic Cleansing Prevents Deaths in Newborns

By HospiMedica International staff writers
Posted on 15 Mar 2015
A new review concludes that using a low-cost antiseptic to cleanse the umbilical cord after birth could help reduce infant death rates in developing countries by 12%.

Researchers at the Indian Council of Medical Research (New Delhi, India), Kasturba Hospital (Delhi, India), and other institutions conducted a systemic review of 12 trials involving chlorhexidine cleansing in over 87,000 newborns worldwide. More...
Seven of the trials took place in South-East Asia, two in Africa, two in Europe, and one South America. Of the 12 trials, the five carried out in community settings, which involved 72,030 newborns (including home births), provided the highest quality evidence.

The results showed that cleansing umbilical cords with chlorhexidine reduced infant deaths by 12%, compared to keeping cords dry. Using chlorhexidine also halved the number of newborn babies that suffered from omphalitis, a swelling of the cord stump commonly caused by bacterial infections. The results also revealed, however, that maternal vaginal chlorhexidine use probably leads to no difference in neonatal mortality or risk of infections in the hospital setting. The review was published in the March 2015 issue of the Cochrane Library.

“The greatest benefits were seen in the South-East Asian studies. The results from African studies are less convincing, so we would like to see whether the results from ongoing trials in Zambia and Tanzania can substantiate this evidence,” said lead author Anju Sinha, MD, of the Indian Council of Medical Research. “Based on our review, using chlorhexidine to clean the umbilical cord saves newborn babies lives.”

Chlorhexidine salts dissociate and release the positively charged chlorhexidine cation molecule, which causes a bactericidal effect by binding to negatively charged cell walls. At low concentrations, a bacteriostatic effect occurs; at high concentrations, membrane disruption results in cell death. It can be applied topically as a gel, wash, or powder. In maternity care, it can be used either as a vaginal disinfectant to prevent the spread of bacteria from mother to baby, or as a cleansing agent for the newborn baby's skin or umbilical cord.

Related Links:

Indian Council of Medical Research
Kasturba Hospital



Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
IV Therapy Cart
Avalo I.V Therapy Cart
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.